Posted by Michael Wonder on 18 Sep 2024
EMA publishes agenda for 16-19 September 2024 CHMP meeting
16 September 2024 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Aflibercept
- Mirvetuximab soravtansine
- Marstacimab
- Serplulimab
- Pomalidomide
- Lutetium Lu 177 chloride
